Article Image

Vaccine Education Summit 2016 Speaker - James Lyons-Weiler

Written by Ernest Hancock Subject: Events: Arizona

www.VaccineEducationSummit.com

Radio/Video Shows with Ernest Hancock

Dr. James Lyons-Weiler is the founder and CEO of the Institute for Pure and Applied Knowledge, also known as IPAK. He is the author of three books, one on Ebola, another on Cures vs. Profits and a third on The Environmental and Genetic Causes of Autism". He, along with other scientists at IPAK, perform research in the public interest aimed at finding ways to reduce human suffering. He lives in Western PA with his fiance Gracie and his two well-adjusted teen aged boys.

Webpages:

http://ipaknowledge.org/

https://jameslyonsweiler.com/

==============================

James Lyons-Weiler's Books...

1. The Environmental and Genetic Causes of Autism

The Environmental and Genetic Causes of Autism delves deep into the full body of past and current research to reveal how genetic predispositions and environmental factors can combine to produce the conditions autism and autism spectrum disorders (ASD).

To make this groundbreaking volume, Dr. James Lyons-Weiler combed through the past fifty years of published research on autism, exploring subjects such as genetic variation, mechanisms of neurotoxicity of metals and pesticides, and the central and combined roles of each in causing autism.

Lyons-Weiler provides a major overview of all aspects of the condition of autism, reviews changes in diagnoses and treatments, and explains how genetic information can be used to tailor effective treatments, and sometimes reversals, of the symptoms. He also presents practical forward-looking suggestions on how to design future studies to facilitate the discovery of biomarkers for autism risk and how to classify the full range of autism spectrum disorders.

Autism is considered one of the most mystifying conditions of our day, and alarmed scientists, doctors, politicians, and parents are desperately trying to understand why the condition is escalating. According to the CDC, rates in the United States have risen from an estimated one in two thousand children in 1980, to one in sixty-eight in 2012, and a new National Health Interview Survey shows a rate of one in forty-five. By the time you read this book, that number may have changed yet again.

While most autism researchers focus on either environmental or genetic causes of autism, Lyons-Weiler's opus demonstrates that to fully understand the condition and to finally put its rate on the decrease, it is essential to pay attention to the science showing how the two classes of factors interact.

2. Cures vs. Profits: Successes in Translational Research

Did you ever wonder whether doctors want cures, or just treatments?

Did you know ...

-Grapefruit can interact with over 100 drugs, but it may be useful for reducing blood pressure and for weight loss?

ADHD over diagnosis is now recognized widely as a fact, and there are existing — and new ways — to avoid a misdiagnosis?

-Studies have been conducted demonstrating the utility of Omega 3 fatty acids, meditation, yoga, and melatonin for some important symptoms of ADHD, including executive functions?

-Did you know vaccines have saved millions of lives?  But are they safe?

-Breast cancer rates are declining in the US, but have been steadily increasing in Japan?

-Doctors are getting better at predicting which chemotherapy will, and will not work, on certain cancers?

-There are vaccines against cancer?

This book reviews recent key, hard-won successes and findings from recent biomedical research. Written by one of the most ardent defenders of the public trust in science, it provides an accessible, detailed look at successes in translational biomedical and clinical research. The author provides an optimistic, forward-looking view for the possibility of change for the public good, cutting through the controversy and gets to very core of each topic. The public can be optimistic about the future of medicine, but only if they learn the facts of these advances, and learn what their doctors should be expected to know.

Highly referenced, and filled with interviews from experts and people directly involved in the research behind the new facts in each chapter, this book is a rich source of information on advances in biomedicine that you will want to share with your family & friends.

Readership: Lay public, scientists, doctors, politicians, policy makers, public health workers, health care worker, investors.

3. Ebola: An Evolving Story

The book is a narrative of the unfolding of the Ebola virus disease outbreak from a scientific view point. The author provides an analysis of the scientific basis of public health policies that have influenced the public's, and the medical community's, abilities to understand the virus and the disease. This is done in the context of providing insights into the biology of the virus, and exploring open questions, including its likely modes of transmission. The author has included citations from the scientific literature and the press, as well as quotes from expert interviews. The book will help sort out the fact from fiction, given the confusion that arose after the virus arrived in the US. The author used his objective research skills and knowledge of evolutionary genetics and molecular biology to find out what was known, and what questions remained unanswered, and even what questions remained unasked.

Written in an accessible style, it is intended for the educated general public, scientists, policy makers, health care workers, and politicians. It delves into the problems of trying to derive a logic-based understanding of a highly lethal emerging disease in 2014, when research funding cuts have gutted research institutions, and when public health institutions really were woefully unprepared. It is a highly distinct narrative analysis that is sure to stimulate new research and thinking in public policy. It will inform thousands of people of the nature of the virus, how it works, in terms they are likely to be able to understand. It will allow others to rapidly catch up with the story of Ebola.

Join us on our Social Networks:

 

Share this page with your friends on your favorite social network:

GoldMoney